Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zephyr Surgical Implants is a private Swiss medical device company focused on implantable prosthetic devices for urology, andrology, gynecology, and gender-affirming surgery. The company develops, manufactures, assembles, and tests its products in Switzerland and markets them internationally through subsidiaries and distributors. Its core commercial portfolio includes the ZSI 375 PF artificial urinary sphincter and multiple penile implant systems, including products designed for cisgender male erectile dysfunction and transgender men after phalloplasty or metoidioplasty. The company positions itself as a specialist in implantable solutions for urinary incontinence and erectile restoration rather than a drug developer. ZSI appears to be a commercial-stage, family-run device manufacturer with global distribution across more than 70 countries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zephyr Surgical Implants.